7EQG image
Entry Detail
PDB ID:
7EQG
EMDB ID:
Title:
Structure of Csy-AcrIF5
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-05-01
Release Date:
2022-03-09
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Type I-F CRISPR-associated protein Csy1
Chain IDs:P (auth: B)
Chain Length:434
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polypeptide(L)
Description:CRISPR type I-F/YPEST-associated protein Csy2
Chain IDs:A (auth: C)
Chain Length:327
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polypeptide(L)
Description:CRISPR-associated protein Csy3
Chain IDs:B (auth: D), C (auth: E), D (auth: F), E (auth: G), F (auth: H), G (auth: I)
Chain Length:342
Number of Molecules:6
Biological Source:Pseudomonas aeruginosa
Polymer Type:polypeptide(L)
Description:AcrIF5
Chain IDs:H (auth: J), I (auth: K), M (auth: P), N (auth: Q), O (auth: R)
Chain Length:79
Number of Molecules:5
Biological Source:Pseudomonas aeruginosa
Polymer Type:polypeptide(L)
Description:type I-F CRISPR-associated endoribonuclease Cas6/Csy4
Chain IDs:J (auth: L)
Chain Length:187
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polyribonucleotide
Description:RNA (60-MER)
Chain IDs:K (auth: M)
Chain Length:60
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polydeoxyribonucleotide
Description:DNA (54-MER)
Chain IDs:L (auth: N)
Chain Length:54
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polydeoxyribonucleotide
Description:DNA (54-MER)
Chain IDs:Q (auth: O)
Chain Length:54
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Ligand Molecules
Primary Citation
AcrIF5 specifically targets DNA-bound CRISPR-Cas surveillance complex for inhibition.
Nat.Chem.Biol. 18 670 677 (2022)
PMID: 35301482 DOI: 10.1038/s41589-022-00995-8

Abstact

CRISPR-Cas systems are prokaryotic antiviral systems, and phages use anti-CRISPR proteins (Acrs) to inactivate these systems. Here we present structural and functional analyses of AcrIF5, exploring its unique anti-CRISPR mechanism. AcrIF5 shows binding specificity only for the target DNA-bound form of the crRNA-guided surveillance (Csy) complex, but not the apo Csy complex from the type I-F CRISPR-Cas system. We solved the structure of the Csy-dsDNA-AcrIF5 complex, revealing that the conformational changes of the Csy complex caused by dsDNA binding dictate the binding specificity for the Csy-dsDNA complex by AcrIF5. Mechanistically, five AcrIF5 molecules bind one Csy-dsDNA complex, which destabilizes the helical bundle domain of Cas8f, thus preventing subsequent Cas2/3 recruitment. AcrIF5 exists in symbiosis with AcrIF3, which blocks Cas2/3 recruitment. This attack on the recruitment event stands in contrast to the conventional mechanisms of blocking binding of target DNA. Overall, our study reveals an unprecedented mechanism of CRISPR-Cas inhibition by AcrIF5.

Legend

Protein

Chemical

Disease

Primary Citation of related structures